XLS Medical Direct - Fat Binder Sachets 

LOSE UP TO 3x MORE WEIGHT THAN WITH A DIET ALONE WITH A NEW CONVENIENT FORMULATION IN POWDER STICKS.

SO EASY to use! DIRECT DOSE,
NO WATER NEEDED!

NEW XLS Medical Fat Binder Direct makes weight management easier than ever before thanks to its convenient stock format. It is an ideal tool for losing weight and keeping it off.

XLS Medical Fat Binder Direct is also good for your health and has a proven effect on:

•    Cholesterol reduction

•    Metabolic syndrome reduction

How to take NEW XLS Medical Fat Binder Direct?

•              Just take 1 stick, 3 times a day, directly into the mouth. No water needed.

•              If you are eating, the stick should be taken

•              after meals.

•              Do not exceed 3 sticks a day.

•              Take XLS Medical Fat Binder Direct one month

•              or more, depending on your weight loss targets.

•              For beneficial actions of fibers on gastrointestinal transit,

•              it is recommended to drink at least 2L of water a day.

•              he excellent fat absorption capacity of XLS Medical Fat Binder has been proven in numerous clinical studies:
 

•    XLS Medical Fat Binder reduces fat absorption by up to 28% with no undesirable side effects

•    XLS Medical Fat Binder reduces LDL-Cholesterol (bad cholesterol) by 10% within 14 days⁴

•    XLS Medical Fat Binder reduces metabolic syndrome by 39% within 42 days⁴

•    XLS Medical Fat Binder has a proven effect on the feeling of fullness: 80% of patients reported a moderate to high increase in fullness²

•    XLS Medical Fat Binder helps you to lose up to 3X more weight than with a diet alone.

•    All these results are achieved with no undesirable side effects

1. In vivo Pilot Clinical Study, placebo-controlled, double-blind clinical study, conducted by CERN, (Centre d’Enseignement et de Recherche en Nutrition) in France, 2003.

2. In vivo, 2-armed, randomised, placebo-controlled, double-blind study, conducted in Germany, 2009.

3. Double-blind, randomized, placebo-controlled, crossover clinical investigation to evaluate the effect of Litramine on fecal fat excretion in healthy subjects, Germany, 2012.

4. Linarès E. et al., The effect of NeOpuntia on Blood Lipid Parameters – Risk Factors for the Metabolic Syndrome (Syndrome X), Advances in Therapy, September/October 2007.